ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31729-100mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1)
|
0 | C16H13NO2 | |
GC31729-50mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1)
|
0 | C16H13NO2 | |
GC31729-10mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1)
|
0 | C16H13NO2 | |
GC31729-5mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1)
|
0 | C16H13NO2 | |
GC31729-10mM(1mLinDMSO) |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1)
|
0 | C16H13NO2 | |
GC31728-50mg |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31728-25mg |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31728-10mg |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31728-5mg |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31728-1mg |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31728-10mM(1mLinDMSO) |
|
1187187-10-5 |
AN3199
|
0 | C17H18BNO5 | |
GC31727-1g |
|
1949-20-8 |
Oxolamine citrate (SKF-9976 citrate)
|
0 | C20H27N3O8 | |
GC31727-10mM(1mLinDMSO) |
|
1949-20-8 |
Oxolamine citrate (SKF-9976 citrate)
|
0 | C20H27N3O8 | |
GC31726-100mg |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31726-50mg |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31726-10mg |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31726-5mg |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31726-1mg |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31726-10mM(1mLinDMSO) |
|
791587-67-2 |
cFMS-IN-2
|
0 | C19H21N3O3 | |
GC31725-10mg |
|
506-32-1 |
Arachidonic acid (Immunocytophyt)
|
0 | C20H32O2 | |